0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Heparin Market Research Report 2026
Published Date: 2026-02-11
|
Report Code: QYRE-Auto-12130
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Heparin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Heparin Market Research Report 2026

Code: QYRE-Auto-12130
Report
2026-02-11
Pages:121
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Heparin Market Size

The global Heparin market was valued at US$ 1469 million in 2025 and is anticipated to reach US$ 2462 million by 2032, at a CAGR of 7.8% from 2026 to 2032.

Heparin Market

Heparin Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Heparin competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2024, global Heparin production reached approximately 23,498 billion units , with an average global market price of around US$ 52,147 per billion units. Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. In this report, we mainly study the Heparin API.
Global key players of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, etc. The top five manufacturers hold a share about 54%. China is dominating the global Heparin market, has a share over 65% in terms of production. Europe and Asia-Pacific are the two largest market, both having a share about 34%, followed by North America, with a share about 30 percent.
The heparin API market is primarily driven by the rising global prevalence of cardiovascular and thromboembolic diseases, along with increasing surgical procedures. Growing aging populations and higher obesity rates contribute to sustained demand for anticoagulants. Additionally, heparin's use in treating COVID-19-associated thrombotic complications has further propelled market expansion. Pharmaceutical industry advancements in emerging markets (e.g., China and India) and the biopharmaceutical sector's demand for high-quality heparin also fuel market growth.
Key trends in the heparin API market include: 1) a technological shift from animal-sourced heparin (porcine intestinal mucosa extraction) to synthetic alternatives (e.g., low-molecular-weight heparin); 2) stringent regulatory requirements for supply chain traceability and quality control; 3) intensified competition from biosimilars, driving process optimization and cost reduction; and 4) the rise of local pharmaceutical players in emerging markets, diversifying the global heparin supply chain.
This report delivers a comprehensive overview of the global Heparin market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Heparin. The Heparin market size, estimates, and forecasts are provided in terms of sales volume (billion units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Heparin market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Heparin manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Heparin Market Report

Report Metric Details
Report Name Heparin Market
Accounted market size in 2025 US$ 1469 million
Forecasted market size in 2032 US$ 2462 million
CAGR 7.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Heparin Sodium
  • Heparin Calcium
by Application
  • UFH
  • LMWH
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Pfizer, Bioibérica, Changzhou Qianhong Biopharma, Nanjing King-friend Biochemical Pharmaceutical, Hebei Changshan Biochemical Pharmaceutical, Qingdao Jiulong Biopharmaceutical, Opocrin, Dongying Tiandong Pharmaceutical, Aspen Oss, Yino Pharma, Nanjing Xinbai Pharmaceutical, Hubei Enoray Biopharmaceutical, Cisen Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Heparin manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Heparin sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Heparin Market growing?

Ans: The Heparin Market witnessing a CAGR of 7.8% during the forecast period 2026-2032.

What is the Heparin Market size in 2032?

Ans: The Heparin Market size in 2032 will be US$ 2462 million.

What is the market share of major companies in Heparin Market?

Ans: The top five manufacturers hold a share about 54%.

What is the Heparin Market production share by region?

Ans: China is dominating the global Heparin market, has a share over 65% in terms of production.

Who are the main players in the Heparin Market report?

Ans: The main players in the Heparin Market are Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Pfizer, Bioibérica, Changzhou Qianhong Biopharma, Nanjing King-friend Biochemical Pharmaceutical, Hebei Changshan Biochemical Pharmaceutical, Qingdao Jiulong Biopharmaceutical, Opocrin, Dongying Tiandong Pharmaceutical, Aspen Oss, Yino Pharma, Nanjing Xinbai Pharmaceutical, Hubei Enoray Biopharmaceutical, Cisen Pharmaceutical

What are the Application segmentation covered in the Heparin Market report?

Ans: The Applications covered in the Heparin Market report are UFH, LMWH

What are the Type segmentation covered in the Heparin Market report?

Ans: The Types covered in the Heparin Market report are Heparin Sodium, Heparin Calcium

1 Heparin Market Overview
1.1 Product Definition
1.2 Heparin by Type
1.2.1 Global Heparin Market Value by Type: 2025 vs 2032
1.2.2 Heparin Sodium
1.2.3 Heparin Calcium
1.3 Heparin by Application
1.3.1 Global Heparin Market Value by Application: 2025 vs 2032
1.3.2 UFH
1.3.3 LMWH
1.4 Global Heparin Market Size Estimates and Forecasts
1.4.1 Global Heparin Revenue 2021–2032
1.4.2 Global Heparin Sales 2021–2032
1.4.3 Global Heparin Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Heparin Market Competition by Manufacturers
2.1 Global Heparin Sales Market Share by Manufacturers (2021–2026)
2.2 Global Heparin Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Heparin Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Heparin, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Heparin, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Heparin, Product Types and Applications
2.7 Global Key Manufacturers of Heparin, Date of Entry into the Industry
2.8 Global Heparin Market Competitive Situation and Trends
2.8.1 Global Heparin Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Heparin Players Market Share by Revenue
2.8.3 Global Heparin Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Heparin Market Scenario by Region
3.1 Global Heparin Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Heparin Sales by Region: 2021–2032
3.2.1 Global Heparin Sales by Region: 2021–2026
3.2.2 Global Heparin Sales by Region: 2027–2032
3.3 Global Heparin Revenue by Region: 2021–2032
3.3.1 Global Heparin Revenue by Region: 2021–2026
3.3.2 Global Heparin Revenue by Region: 2027–2032
3.4 North America Heparin Market Facts & Figures by Country
3.4.1 North America Heparin Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Heparin Sales by Country (2021–2032)
3.4.3 North America Heparin Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Heparin Market Facts & Figures by Country
3.5.1 Europe Heparin Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Heparin Sales by Country (2021–2032)
3.5.3 Europe Heparin Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Heparin Market Facts & Figures by Region
3.6.1 Asia Pacific Heparin Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Heparin Sales by Region (2021–2032)
3.6.3 Asia Pacific Heparin Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Heparin Market Facts & Figures by Country
3.7.1 Latin America Heparin Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Heparin Sales by Country (2021–2032)
3.7.3 Latin America Heparin Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Heparin Market Facts & Figures by Country
3.8.1 Middle East and Africa Heparin Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Heparin Sales by Country (2021–2032)
3.8.3 Middle East and Africa Heparin Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Heparin Sales by Type (2021–2032)
4.1.1 Global Heparin Sales by Type (2021–2026)
4.1.2 Global Heparin Sales by Type (2027–2032)
4.1.3 Global Heparin Sales Market Share by Type (2021–2032)
4.2 Global Heparin Revenue by Type (2021–2032)
4.2.1 Global Heparin Revenue by Type (2021–2026)
4.2.2 Global Heparin Revenue by Type (2027–2032)
4.2.3 Global Heparin Revenue Market Share by Type (2021–2032)
4.3 Global Heparin Price by Type (2021–2032)
5 Segment by Application
5.1 Global Heparin Sales by Application (2021–2032)
5.1.1 Global Heparin Sales by Application (2021–2026)
5.1.2 Global Heparin Sales by Application (2027–2032)
5.1.3 Global Heparin Sales Market Share by Application (2021–2032)
5.2 Global Heparin Revenue by Application (2021–2032)
5.2.1 Global Heparin Revenue by Application (2021–2026)
5.2.2 Global Heparin Revenue by Application (2027–2032)
5.2.3 Global Heparin Revenue Market Share by Application (2021–2032)
5.3 Global Heparin Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Shenzhen Hepalink Pharmaceutical
6.1.1 Shenzhen Hepalink Pharmaceutical Company Information
6.1.2 Shenzhen Hepalink Pharmaceutical Description and Business Overview
6.1.3 Shenzhen Hepalink Pharmaceutical Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Shenzhen Hepalink Pharmaceutical Heparin Product Portfolio
6.1.5 Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
6.2 Yantai Dongcheng Pharmaceutical
6.2.1 Yantai Dongcheng Pharmaceutical Company Information
6.2.2 Yantai Dongcheng Pharmaceutical Description and Business Overview
6.2.3 Yantai Dongcheng Pharmaceutical Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Yantai Dongcheng Pharmaceutical Heparin Product Portfolio
6.2.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Pfizer Heparin Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Bioibérica
6.4.1 Bioibérica Company Information
6.4.2 Bioibérica Description and Business Overview
6.4.3 Bioibérica Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Bioibérica Heparin Product Portfolio
6.4.5 Bioibérica Recent Developments/Updates
6.5 Changzhou Qianhong Biopharma
6.5.1 Changzhou Qianhong Biopharma Company Information
6.5.2 Changzhou Qianhong Biopharma Description and Business Overview
6.5.3 Changzhou Qianhong Biopharma Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Changzhou Qianhong Biopharma Heparin Product Portfolio
6.5.5 Changzhou Qianhong Biopharma Recent Developments/Updates
6.6 Nanjing King-friend Biochemical Pharmaceutical
6.6.1 Nanjing King-friend Biochemical Pharmaceutical Company Information
6.6.2 Nanjing King-friend Biochemical Pharmaceutical Description and Business Overview
6.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Product Portfolio
6.6.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
6.7 Hebei Changshan Biochemical Pharmaceutical
6.7.1 Hebei Changshan Biochemical Pharmaceutical Company Information
6.7.2 Hebei Changshan Biochemical Pharmaceutical Description and Business Overview
6.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin Product Portfolio
6.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
6.8 Qingdao Jiulong Biopharmaceutical
6.8.1 Qingdao Jiulong Biopharmaceutical Company Information
6.8.2 Qingdao Jiulong Biopharmaceutical Description and Business Overview
6.8.3 Qingdao Jiulong Biopharmaceutical Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Qingdao Jiulong Biopharmaceutical Heparin Product Portfolio
6.8.5 Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
6.9 Opocrin
6.9.1 Opocrin Company Information
6.9.2 Opocrin Description and Business Overview
6.9.3 Opocrin Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Opocrin Heparin Product Portfolio
6.9.5 Opocrin Recent Developments/Updates
6.10 Dongying Tiandong Pharmaceutical
6.10.1 Dongying Tiandong Pharmaceutical Company Information
6.10.2 Dongying Tiandong Pharmaceutical Description and Business Overview
6.10.3 Dongying Tiandong Pharmaceutical Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Dongying Tiandong Pharmaceutical Heparin Product Portfolio
6.10.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
6.11 Aspen Oss
6.11.1 Aspen Oss Company Information
6.11.2 Aspen Oss Description and Business Overview
6.11.3 Aspen Oss Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Aspen Oss Heparin Product Portfolio
6.11.5 Aspen Oss Recent Developments/Updates
6.12 Yino Pharma
6.12.1 Yino Pharma Company Information
6.12.2 Yino Pharma Description and Business Overview
6.12.3 Yino Pharma Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Yino Pharma Heparin Product Portfolio
6.12.5 Yino Pharma Recent Developments/Updates
6.13 Nanjing Xinbai Pharmaceutical
6.13.1 Nanjing Xinbai Pharmaceutical Company Information
6.13.2 Nanjing Xinbai Pharmaceutical Description and Business Overview
6.13.3 Nanjing Xinbai Pharmaceutical Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Nanjing Xinbai Pharmaceutical Heparin Product Portfolio
6.13.5 Nanjing Xinbai Pharmaceutical Recent Developments/Updates
6.14 Hubei Enoray Biopharmaceutical
6.14.1 Hubei Enoray Biopharmaceutical Company Information
6.14.2 Hubei Enoray Biopharmaceutical Description and Business Overview
6.14.3 Hubei Enoray Biopharmaceutical Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Hubei Enoray Biopharmaceutical Heparin Product Portfolio
6.14.5 Hubei Enoray Biopharmaceutical Recent Developments/Updates
6.15 Cisen Pharmaceutical
6.15.1 Cisen Pharmaceutical Company Information
6.15.2 Cisen Pharmaceutical Description and Business Overview
6.15.3 Cisen Pharmaceutical Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Cisen Pharmaceutical Heparin Product Portfolio
6.15.5 Cisen Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Heparin Industry Chain Analysis
7.2 Heparin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Heparin Production Mode & Process Analysis
7.4 Heparin Sales and Marketing
7.4.1 Heparin Sales Channels
7.4.2 Heparin Distributors
7.5 Heparin Customer Analysis
8 Heparin Market Dynamics
8.1 Heparin Industry Trends
8.2 Heparin Market Drivers
8.3 Heparin Market Challenges
8.4 Heparin Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Heparin Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Heparin Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Heparin Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Heparin Sales (billion units) of Key Manufacturers (2021–2026)
 Table 5. Global Heparin Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Heparin Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Heparin Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Heparin Average Price (US$/billion units) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Heparin, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Heparin, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Heparin, Product Types and Applications
 Table 12. Global Key Manufacturers of Heparin, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Heparin Companies by Tier (Tier 1, Tier 2, Tier 3), based on Heparin Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Heparin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Heparin Sales by Region (billion units), 2021–2026
 Table 18. Global Heparin Sales Market Share by Region (2021–2026)
 Table 19. Global Heparin Sales by Region (billion units), 2027–2032
 Table 20. Global Heparin Sales Market Share by Region (2027–2032)
 Table 21. Global Heparin Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Heparin Revenue Market Share by Region (2021–2026)
 Table 23. Global Heparin Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Heparin Revenue Market Share by Region (2027–2032)
 Table 25. North America Heparin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Heparin Sales by Country (billion units), 2021–2026
 Table 27. North America Heparin Sales by Country (billion units), 2027–2032
 Table 28. North America Heparin Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Heparin Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Heparin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Heparin Sales by Country (billion units), 2021–2026
 Table 32. Europe Heparin Sales by Country (billion units), 2027–2032
 Table 33. Europe Heparin Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Heparin Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Heparin Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Heparin Sales by Region (billion units), 2021–2026
 Table 37. Asia Pacific Heparin Sales by Region (billion units), 2027–2032
 Table 38. Asia Pacific Heparin Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Heparin Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Heparin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Heparin Sales by Country (billion units), 2021–2026
 Table 42. Latin America Heparin Sales by Country (billion units), 2027–2032
 Table 43. Latin America Heparin Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Heparin Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Heparin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Heparin Sales by Country (billion units), 2021–2026
 Table 47. Middle East and Africa Heparin Sales by Country (billion units), 2027–2032
 Table 48. Middle East and Africa Heparin Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Heparin Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Heparin Sales (billion units) by Type (2021–2026)
 Table 51. Global Heparin Sales (billion units) by Type (2027–2032)
 Table 52. Global Heparin Sales Market Share by Type (2021–2026)
 Table 53. Global Heparin Sales Market Share by Type (2027–2032)
 Table 54. Global Heparin Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Heparin Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Heparin Revenue Market Share by Type (2021–2026)
 Table 57. Global Heparin Revenue Market Share by Type (2027–2032)
 Table 58. Global Heparin Price (US$/billion units) by Type (2021–2026)
 Table 59. Global Heparin Price (US$/billion units) by Type (2027–2032)
 Table 60. Global Heparin Sales (billion units) by Application (2021–2026)
 Table 61. Global Heparin Sales (billion units) by Application (2027–2032)
 Table 62. Global Heparin Sales Market Share by Application (2021–2026)
 Table 63. Global Heparin Sales Market Share by Application (2027–2032)
 Table 64. Global Heparin Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Heparin Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Heparin Revenue Market Share by Application (2021–2026)
 Table 67. Global Heparin Revenue Market Share by Application (2027–2032)
 Table 68. Global Heparin Price (US$/billion units) by Application (2021–2026)
 Table 69. Global Heparin Price (US$/billion units) by Application (2027–2032)
 Table 70. Shenzhen Hepalink Pharmaceutical Company Information
 Table 71. Shenzhen Hepalink Pharmaceutical Description and Business Overview
 Table 72. Shenzhen Hepalink Pharmaceutical Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units), and Gross Margin (2021–2026)
 Table 73. Shenzhen Hepalink Pharmaceutical Heparin Product
 Table 74. Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
 Table 75. Yantai Dongcheng Pharmaceutical Company Information
 Table 76. Yantai Dongcheng Pharmaceutical Description and Business Overview
 Table 77. Yantai Dongcheng Pharmaceutical Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units), and Gross Margin (2021–2026)
 Table 78. Yantai Dongcheng Pharmaceutical Heparin Product
 Table 79. Yantai Dongcheng Pharmaceutical Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units), and Gross Margin (2021–2026)
 Table 83. Pfizer Heparin Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Bioibérica Company Information
 Table 86. Bioibérica Description and Business Overview
 Table 87. Bioibérica Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units), and Gross Margin (2021–2026)
 Table 88. Bioibérica Heparin Product
 Table 89. Bioibérica Recent Developments/Updates
 Table 90. Changzhou Qianhong Biopharma Company Information
 Table 91. Changzhou Qianhong Biopharma Description and Business Overview
 Table 92. Changzhou Qianhong Biopharma Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units), and Gross Margin (2021–2026)
 Table 93. Changzhou Qianhong Biopharma Heparin Product
 Table 94. Changzhou Qianhong Biopharma Recent Developments/Updates
 Table 95. Nanjing King-friend Biochemical Pharmaceutical Company Information
 Table 96. Nanjing King-friend Biochemical Pharmaceutical Description and Business Overview
 Table 97. Nanjing King-friend Biochemical Pharmaceutical Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units), and Gross Margin (2021–2026)
 Table 98. Nanjing King-friend Biochemical Pharmaceutical Heparin Product
 Table 99. Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
 Table 100. Hebei Changshan Biochemical Pharmaceutical Company Information
 Table 101. Hebei Changshan Biochemical Pharmaceutical Description and Business Overview
 Table 102. Hebei Changshan Biochemical Pharmaceutical Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units), and Gross Margin (2021–2026)
 Table 103. Hebei Changshan Biochemical Pharmaceutical Heparin Product
 Table 104. Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
 Table 105. Qingdao Jiulong Biopharmaceutical Company Information
 Table 106. Qingdao Jiulong Biopharmaceutical Description and Business Overview
 Table 107. Qingdao Jiulong Biopharmaceutical Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units), and Gross Margin (2021–2026)
 Table 108. Qingdao Jiulong Biopharmaceutical Heparin Product
 Table 109. Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
 Table 110. Opocrin Company Information
 Table 111. Opocrin Description and Business Overview
 Table 112. Opocrin Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units), and Gross Margin (2021–2026)
 Table 113. Opocrin Heparin Product
 Table 114. Opocrin Recent Developments/Updates
 Table 115. Dongying Tiandong Pharmaceutical Company Information
 Table 116. Dongying Tiandong Pharmaceutical Description and Business Overview
 Table 117. Dongying Tiandong Pharmaceutical Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units), and Gross Margin (2021–2026)
 Table 118. Dongying Tiandong Pharmaceutical Heparin Product
 Table 119. Dongying Tiandong Pharmaceutical Recent Developments/Updates
 Table 120. Aspen Oss Company Information
 Table 121. Aspen Oss Description and Business Overview
 Table 122. Aspen Oss Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units), and Gross Margin (2021–2026)
 Table 123. Aspen Oss Heparin Product
 Table 124. Aspen Oss Recent Developments/Updates
 Table 125. Yino Pharma Company Information
 Table 126. Yino Pharma Description and Business Overview
 Table 127. Yino Pharma Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units), and Gross Margin (2021–2026)
 Table 128. Yino Pharma Heparin Product
 Table 129. Yino Pharma Recent Developments/Updates
 Table 130. Nanjing Xinbai Pharmaceutical Company Information
 Table 131. Nanjing Xinbai Pharmaceutical Description and Business Overview
 Table 132. Nanjing Xinbai Pharmaceutical Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units), and Gross Margin (2021–2026)
 Table 133. Nanjing Xinbai Pharmaceutical Heparin Product
 Table 134. Nanjing Xinbai Pharmaceutical Recent Developments/Updates
 Table 135. Hubei Enoray Biopharmaceutical Company Information
 Table 136. Hubei Enoray Biopharmaceutical Description and Business Overview
 Table 137. Hubei Enoray Biopharmaceutical Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units), and Gross Margin (2021–2026)
 Table 138. Hubei Enoray Biopharmaceutical Heparin Product
 Table 139. Hubei Enoray Biopharmaceutical Recent Developments/Updates
 Table 140. Cisen Pharmaceutical Company Information
 Table 141. Cisen Pharmaceutical Description and Business Overview
 Table 142. Cisen Pharmaceutical Heparin Sales (billion units), Revenue (US$ Million), Price (US$/billion units), and Gross Margin (2021–2026)
 Table 143. Cisen Pharmaceutical Heparin Product
 Table 144. Cisen Pharmaceutical Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Heparin Distributors List
 Table 148. Heparin Customers List
 Table 149. Heparin Market Trends
 Table 150. Heparin Market Drivers
 Table 151. Heparin Market Challenges
 Table 152. Heparin Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Heparin
 Figure 2. Global Heparin Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Heparin Market Share by Type: 2025 & 2032
 Figure 4. Heparin Sodium Product Picture
 Figure 5. Heparin Calcium Product Picture
 Figure 6. Global Heparin Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Heparin Market Share by Application: 2025 & 2032
 Figure 8. UFH
 Figure 9. LMWH
 Figure 10. Global Heparin Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Heparin Market Size (US$ Million), 2021–2032
 Figure 12. Global Heparin Sales (billion units), 2021–2032
 Figure 13. Global Heparin Average Price (US$/billion units), 2021–2032
 Figure 14. Heparin Report Years Considered
 Figure 15. Heparin Sales Share by Manufacturers in 2025
 Figure 16. Global Heparin Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Heparin Players: Market Share by Revenue in Heparin in 2025
 Figure 18. Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Heparin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Heparin Sales Market Share by Country (2021–2032)
 Figure 21. North America Heparin Revenue Market Share by Country (2021–2032)
 Figure 22. United States Heparin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Heparin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Heparin Sales Market Share by Country (2021–2032)
 Figure 25. Europe Heparin Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Heparin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Heparin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Heparin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Heparin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Heparin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Heparin Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Heparin Revenue Market Share by Region (2021–2032)
 Figure 33. China Heparin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Heparin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Heparin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Heparin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Heparin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Taiwan Heparin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Indonesia Heparin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Thailand Heparin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Malaysia Heparin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Philippines Heparin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Heparin Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Heparin Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Heparin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Heparin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Heparin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Heparin Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Heparin Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Heparin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Heparin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. U.A.E Heparin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Heparin by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Heparin by Type (2021–2032)
 Figure 55. Global Heparin Price (US$/billion units) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Heparin by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Heparin by Application (2021–2032)
 Figure 58. Global Heparin Price (US$/billion units) by Application (2021–2032)
 Figure 59. Heparin Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS